MAPT and Parkinson disease: Pathological hyperphosphorylation and aggregation of tau is a hallmark of neurodegenerative conditions known as tauopathies, including Alzheimer’s disease (AD), Parkinson’s disease (PD), Pick’s disease, and Frontotemporal dementia with Parkinsonism-17 (FTDP-17).